COVID-19 Impact on Global Pet Pharmaceuticals, Market Insights and Forecast to 2026
Pet Pharmaceuticals market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pet Pharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Pet Pharmaceuticals market is segmented into
The Pet Pharmaceuticals market is analysed and market size information is provided by regions (countries).
The key regions covered in the Pet Pharmaceuticals market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pet Pharmaceuticals Market Share Analysis
Pet Pharmaceuticals market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pet Pharmaceuticals business, the date to enter into the Pet Pharmaceuticals market, Pet Pharmaceuticals product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Pet Pharmaceuticals market is segmented into
- Pill
- Injection
- Spray
- Ointment
- Others
- Treatment
- Prevention
The Pet Pharmaceuticals market is analysed and market size information is provided by regions (countries).
The key regions covered in the Pet Pharmaceuticals market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pet Pharmaceuticals Market Share Analysis
Pet Pharmaceuticals market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pet Pharmaceuticals business, the date to enter into the Pet Pharmaceuticals market, Pet Pharmaceuticals product introduction, recent developments, etc.
The major vendors covered:
- Zoetis
- Merck Animal Health
- Merial
- Elanco
- Bayer
- Boehringer Ingolheim
- Novartis
- Virbac Group
- Ceva Sante Animale
- V?toquinol S.A.
1 STUDY COVERAGE
1.1 Pet Pharmaceuticals Product Introduction
1.2 Market Segments
1.3 Key Pet Pharmaceuticals Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pet Pharmaceuticals Market Size Growth Rate by Type
1.4.2 Pill
1.4.3 Injection
1.4.4 Spray
1.4.5 Ointment
1.4.6 Others
1.5 Market by Application
1.5.1 Global Pet Pharmaceuticals Market Size Growth Rate by Application
1.5.2 Treatment
1.5.3 Prevention
1.6 Coronavirus Disease 2019 (Covid-19): Pet Pharmaceuticals Industry Impact
1.6.1 How the Covid-19 is Affecting the Pet Pharmaceuticals Industry
1.6.1.1 Pet Pharmaceuticals Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Pet Pharmaceuticals Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Pet Pharmaceuticals Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Pet Pharmaceuticals Market Size Estimates and Forecasts
2.1.1 Global Pet Pharmaceuticals Revenue 2015-2026
2.1.2 Global Pet Pharmaceuticals Sales 2015-2026
2.2 Pet Pharmaceuticals Market Size by Region: 2020 Versus 2026
2.2.1 Global Pet Pharmaceuticals Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Pet Pharmaceuticals Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL PET PHARMACEUTICALS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Pet Pharmaceuticals Sales by Manufacturers
3.1.1 Pet Pharmaceuticals Sales by Manufacturers (2015-2020)
3.1.2 Pet Pharmaceuticals Sales Market Share by Manufacturers (2015-2020)
3.2 Pet Pharmaceuticals Revenue by Manufacturers
3.2.1 Pet Pharmaceuticals Revenue by Manufacturers (2015-2020)
3.2.2 Pet Pharmaceuticals Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pet Pharmaceuticals Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pet Pharmaceuticals Revenue in 2019
3.2.5 Global Pet Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Pet Pharmaceuticals Price by Manufacturers
3.4 Pet Pharmaceuticals Manufacturing Base Distribution, Product Types
3.4.1 Pet Pharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pet Pharmaceuticals Product Type
3.4.3 Date of International Manufacturers Enter into Pet Pharmaceuticals Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Pet Pharmaceuticals Market Size by Type (2015-2020)
4.1.1 Global Pet Pharmaceuticals Sales by Type (2015-2020)
4.1.2 Global Pet Pharmaceuticals Revenue by Type (2015-2020)
4.1.3 Pet Pharmaceuticals Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pet Pharmaceuticals Market Size Forecast by Type (2021-2026)
4.2.1 Global Pet Pharmaceuticals Sales Forecast by Type (2021-2026)
4.2.2 Global Pet Pharmaceuticals Revenue Forecast by Type (2021-2026)
4.2.3 Pet Pharmaceuticals Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pet Pharmaceuticals Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Pet Pharmaceuticals Market Size by Application (2015-2020)
5.1.1 Global Pet Pharmaceuticals Sales by Application (2015-2020)
5.1.2 Global Pet Pharmaceuticals Revenue by Application (2015-2020)
5.1.3 Pet Pharmaceuticals Price by Application (2015-2020)
5.2 Pet Pharmaceuticals Market Size Forecast by Application (2021-2026)
5.2.1 Global Pet Pharmaceuticals Sales Forecast by Application (2021-2026)
5.2.2 Global Pet Pharmaceuticals Revenue Forecast by Application (2021-2026)
5.2.3 Global Pet Pharmaceuticals Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Pet Pharmaceuticals by Country
6.1.1 North America Pet Pharmaceuticals Sales by Country
6.1.2 North America Pet Pharmaceuticals Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Pet Pharmaceuticals Market Facts & Figures by Type
6.3 North America Pet Pharmaceuticals Market Facts & Figures by Application
7 EUROPE
7.1 Europe Pet Pharmaceuticals by Country
7.1.1 Europe Pet Pharmaceuticals Sales by Country
7.1.2 Europe Pet Pharmaceuticals Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pet Pharmaceuticals Market Facts & Figures by Type
7.3 Europe Pet Pharmaceuticals Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Pet Pharmaceuticals by Region
8.1.1 Asia Pacific Pet Pharmaceuticals Sales by Region
8.1.2 Asia Pacific Pet Pharmaceuticals Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Pet Pharmaceuticals Market Facts & Figures by Type
8.3 Asia Pacific Pet Pharmaceuticals Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Pet Pharmaceuticals by Country
9.1.1 Latin America Pet Pharmaceuticals Sales by Country
9.1.2 Latin America Pet Pharmaceuticals Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Pet Pharmaceuticals Market Facts & Figures by Type
9.3 Central & South America Pet Pharmaceuticals Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Pet Pharmaceuticals by Country
10.1.1 Middle East and Africa Pet Pharmaceuticals Sales by Country
10.1.2 Middle East and Africa Pet Pharmaceuticals Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Pet Pharmaceuticals Market Facts & Figures by Type
10.3 Middle East and Africa Pet Pharmaceuticals Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Zoetis
11.1.1 Zoetis Corporation Information
11.1.2 Zoetis Description, Business Overview and Total Revenue
11.1.3 Zoetis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Zoetis Pet Pharmaceuticals Products Offered
11.1.5 Zoetis Recent Development
11.2 Merck Animal Health
11.2.1 Merck Animal Health Corporation Information
11.2.2 Merck Animal Health Description, Business Overview and Total Revenue
11.2.3 Merck Animal Health Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck Animal Health Pet Pharmaceuticals Products Offered
11.2.5 Merck Animal Health Recent Development
11.3 Merial
11.3.1 Merial Corporation Information
11.3.2 Merial Description, Business Overview and Total Revenue
11.3.3 Merial Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merial Pet Pharmaceuticals Products Offered
11.3.5 Merial Recent Development
11.4 Elanco
11.4.1 Elanco Corporation Information
11.4.2 Elanco Description, Business Overview and Total Revenue
11.4.3 Elanco Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Elanco Pet Pharmaceuticals Products Offered
11.4.5 Elanco Recent Development
11.5 Bayer
11.5.1 Bayer Corporation Information
11.5.2 Bayer Description, Business Overview and Total Revenue
11.5.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Bayer Pet Pharmaceuticals Products Offered
11.5.5 Bayer Recent Development
11.6 Boehringer Ingolheim
11.6.1 Boehringer Ingolheim Corporation Information
11.6.2 Boehringer Ingolheim Description, Business Overview and Total Revenue
11.6.3 Boehringer Ingolheim Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Boehringer Ingolheim Pet Pharmaceuticals Products Offered
11.6.5 Boehringer Ingolheim Recent Development
11.7 Novartis
11.7.1 Novartis Corporation Information
11.7.2 Novartis Description, Business Overview and Total Revenue
11.7.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Novartis Pet Pharmaceuticals Products Offered
11.7.5 Novartis Recent Development
11.8 Virbac Group
11.8.1 Virbac Group Corporation Information
11.8.2 Virbac Group Description, Business Overview and Total Revenue
11.8.3 Virbac Group Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Virbac Group Pet Pharmaceuticals Products Offered
11.8.5 Virbac Group Recent Development
11.9 Ceva Sante Animale
11.9.1 Ceva Sante Animale Corporation Information
11.9.2 Ceva Sante Animale Description, Business Overview and Total Revenue
11.9.3 Ceva Sante Animale Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Ceva Sante Animale Pet Pharmaceuticals Products Offered
11.9.5 Ceva Sante Animale Recent Development
11.10 V?toquinol S.A.
11.10.1 V?toquinol S.A. Corporation Information
11.10.2 V?toquinol S.A. Description, Business Overview and Total Revenue
11.10.3 V?toquinol S.A. Sales, Revenue and Gross Margin (2015-2020)
11.10.4 V?toquinol S.A. Pet Pharmaceuticals Products Offered
11.10.5 V?toquinol S.A. Recent Development
11.1 Zoetis
11.1.1 Zoetis Corporation Information
11.1.2 Zoetis Description, Business Overview and Total Revenue
11.1.3 Zoetis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Zoetis Pet Pharmaceuticals Products Offered
11.1.5 Zoetis Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Pet Pharmaceuticals Market Estimates and Projections by Region
12.1.1 Global Pet Pharmaceuticals Sales Forecast by Regions 2021-2026
12.1.2 Global Pet Pharmaceuticals Revenue Forecast by Regions 2021-2026
12.2 North America Pet Pharmaceuticals Market Size Forecast (2021-2026)
12.2.1 North America: Pet Pharmaceuticals Sales Forecast (2021-2026)
12.2.2 North America: Pet Pharmaceuticals Revenue Forecast (2021-2026)
12.2.3 North America: Pet Pharmaceuticals Market Size Forecast by Country (2021-2026)
12.3 Europe Pet Pharmaceuticals Market Size Forecast (2021-2026)
12.3.1 Europe: Pet Pharmaceuticals Sales Forecast (2021-2026)
12.3.2 Europe: Pet Pharmaceuticals Revenue Forecast (2021-2026)
12.3.3 Europe: Pet Pharmaceuticals Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Pet Pharmaceuticals Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Pet Pharmaceuticals Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Pet Pharmaceuticals Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Pet Pharmaceuticals Market Size Forecast by Region (2021-2026)
12.5 Latin America Pet Pharmaceuticals Market Size Forecast (2021-2026)
12.5.1 Latin America: Pet Pharmaceuticals Sales Forecast (2021-2026)
12.5.2 Latin America: Pet Pharmaceuticals Revenue Forecast (2021-2026)
12.5.3 Latin America: Pet Pharmaceuticals Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Pet Pharmaceuticals Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Pet Pharmaceuticals Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Pet Pharmaceuticals Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Pet Pharmaceuticals Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Pet Pharmaceuticals Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Pet Pharmaceuticals Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Pet Pharmaceuticals Product Introduction
1.2 Market Segments
1.3 Key Pet Pharmaceuticals Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pet Pharmaceuticals Market Size Growth Rate by Type
1.4.2 Pill
1.4.3 Injection
1.4.4 Spray
1.4.5 Ointment
1.4.6 Others
1.5 Market by Application
1.5.1 Global Pet Pharmaceuticals Market Size Growth Rate by Application
1.5.2 Treatment
1.5.3 Prevention
1.6 Coronavirus Disease 2019 (Covid-19): Pet Pharmaceuticals Industry Impact
1.6.1 How the Covid-19 is Affecting the Pet Pharmaceuticals Industry
1.6.1.1 Pet Pharmaceuticals Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Pet Pharmaceuticals Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Pet Pharmaceuticals Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Pet Pharmaceuticals Market Size Estimates and Forecasts
2.1.1 Global Pet Pharmaceuticals Revenue 2015-2026
2.1.2 Global Pet Pharmaceuticals Sales 2015-2026
2.2 Pet Pharmaceuticals Market Size by Region: 2020 Versus 2026
2.2.1 Global Pet Pharmaceuticals Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Pet Pharmaceuticals Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL PET PHARMACEUTICALS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Pet Pharmaceuticals Sales by Manufacturers
3.1.1 Pet Pharmaceuticals Sales by Manufacturers (2015-2020)
3.1.2 Pet Pharmaceuticals Sales Market Share by Manufacturers (2015-2020)
3.2 Pet Pharmaceuticals Revenue by Manufacturers
3.2.1 Pet Pharmaceuticals Revenue by Manufacturers (2015-2020)
3.2.2 Pet Pharmaceuticals Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pet Pharmaceuticals Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pet Pharmaceuticals Revenue in 2019
3.2.5 Global Pet Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Pet Pharmaceuticals Price by Manufacturers
3.4 Pet Pharmaceuticals Manufacturing Base Distribution, Product Types
3.4.1 Pet Pharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pet Pharmaceuticals Product Type
3.4.3 Date of International Manufacturers Enter into Pet Pharmaceuticals Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Pet Pharmaceuticals Market Size by Type (2015-2020)
4.1.1 Global Pet Pharmaceuticals Sales by Type (2015-2020)
4.1.2 Global Pet Pharmaceuticals Revenue by Type (2015-2020)
4.1.3 Pet Pharmaceuticals Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pet Pharmaceuticals Market Size Forecast by Type (2021-2026)
4.2.1 Global Pet Pharmaceuticals Sales Forecast by Type (2021-2026)
4.2.2 Global Pet Pharmaceuticals Revenue Forecast by Type (2021-2026)
4.2.3 Pet Pharmaceuticals Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pet Pharmaceuticals Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Pet Pharmaceuticals Market Size by Application (2015-2020)
5.1.1 Global Pet Pharmaceuticals Sales by Application (2015-2020)
5.1.2 Global Pet Pharmaceuticals Revenue by Application (2015-2020)
5.1.3 Pet Pharmaceuticals Price by Application (2015-2020)
5.2 Pet Pharmaceuticals Market Size Forecast by Application (2021-2026)
5.2.1 Global Pet Pharmaceuticals Sales Forecast by Application (2021-2026)
5.2.2 Global Pet Pharmaceuticals Revenue Forecast by Application (2021-2026)
5.2.3 Global Pet Pharmaceuticals Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Pet Pharmaceuticals by Country
6.1.1 North America Pet Pharmaceuticals Sales by Country
6.1.2 North America Pet Pharmaceuticals Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Pet Pharmaceuticals Market Facts & Figures by Type
6.3 North America Pet Pharmaceuticals Market Facts & Figures by Application
7 EUROPE
7.1 Europe Pet Pharmaceuticals by Country
7.1.1 Europe Pet Pharmaceuticals Sales by Country
7.1.2 Europe Pet Pharmaceuticals Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pet Pharmaceuticals Market Facts & Figures by Type
7.3 Europe Pet Pharmaceuticals Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Pet Pharmaceuticals by Region
8.1.1 Asia Pacific Pet Pharmaceuticals Sales by Region
8.1.2 Asia Pacific Pet Pharmaceuticals Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Pet Pharmaceuticals Market Facts & Figures by Type
8.3 Asia Pacific Pet Pharmaceuticals Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Pet Pharmaceuticals by Country
9.1.1 Latin America Pet Pharmaceuticals Sales by Country
9.1.2 Latin America Pet Pharmaceuticals Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Pet Pharmaceuticals Market Facts & Figures by Type
9.3 Central & South America Pet Pharmaceuticals Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Pet Pharmaceuticals by Country
10.1.1 Middle East and Africa Pet Pharmaceuticals Sales by Country
10.1.2 Middle East and Africa Pet Pharmaceuticals Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Pet Pharmaceuticals Market Facts & Figures by Type
10.3 Middle East and Africa Pet Pharmaceuticals Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Zoetis
11.1.1 Zoetis Corporation Information
11.1.2 Zoetis Description, Business Overview and Total Revenue
11.1.3 Zoetis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Zoetis Pet Pharmaceuticals Products Offered
11.1.5 Zoetis Recent Development
11.2 Merck Animal Health
11.2.1 Merck Animal Health Corporation Information
11.2.2 Merck Animal Health Description, Business Overview and Total Revenue
11.2.3 Merck Animal Health Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck Animal Health Pet Pharmaceuticals Products Offered
11.2.5 Merck Animal Health Recent Development
11.3 Merial
11.3.1 Merial Corporation Information
11.3.2 Merial Description, Business Overview and Total Revenue
11.3.3 Merial Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merial Pet Pharmaceuticals Products Offered
11.3.5 Merial Recent Development
11.4 Elanco
11.4.1 Elanco Corporation Information
11.4.2 Elanco Description, Business Overview and Total Revenue
11.4.3 Elanco Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Elanco Pet Pharmaceuticals Products Offered
11.4.5 Elanco Recent Development
11.5 Bayer
11.5.1 Bayer Corporation Information
11.5.2 Bayer Description, Business Overview and Total Revenue
11.5.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Bayer Pet Pharmaceuticals Products Offered
11.5.5 Bayer Recent Development
11.6 Boehringer Ingolheim
11.6.1 Boehringer Ingolheim Corporation Information
11.6.2 Boehringer Ingolheim Description, Business Overview and Total Revenue
11.6.3 Boehringer Ingolheim Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Boehringer Ingolheim Pet Pharmaceuticals Products Offered
11.6.5 Boehringer Ingolheim Recent Development
11.7 Novartis
11.7.1 Novartis Corporation Information
11.7.2 Novartis Description, Business Overview and Total Revenue
11.7.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Novartis Pet Pharmaceuticals Products Offered
11.7.5 Novartis Recent Development
11.8 Virbac Group
11.8.1 Virbac Group Corporation Information
11.8.2 Virbac Group Description, Business Overview and Total Revenue
11.8.3 Virbac Group Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Virbac Group Pet Pharmaceuticals Products Offered
11.8.5 Virbac Group Recent Development
11.9 Ceva Sante Animale
11.9.1 Ceva Sante Animale Corporation Information
11.9.2 Ceva Sante Animale Description, Business Overview and Total Revenue
11.9.3 Ceva Sante Animale Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Ceva Sante Animale Pet Pharmaceuticals Products Offered
11.9.5 Ceva Sante Animale Recent Development
11.10 V?toquinol S.A.
11.10.1 V?toquinol S.A. Corporation Information
11.10.2 V?toquinol S.A. Description, Business Overview and Total Revenue
11.10.3 V?toquinol S.A. Sales, Revenue and Gross Margin (2015-2020)
11.10.4 V?toquinol S.A. Pet Pharmaceuticals Products Offered
11.10.5 V?toquinol S.A. Recent Development
11.1 Zoetis
11.1.1 Zoetis Corporation Information
11.1.2 Zoetis Description, Business Overview and Total Revenue
11.1.3 Zoetis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Zoetis Pet Pharmaceuticals Products Offered
11.1.5 Zoetis Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Pet Pharmaceuticals Market Estimates and Projections by Region
12.1.1 Global Pet Pharmaceuticals Sales Forecast by Regions 2021-2026
12.1.2 Global Pet Pharmaceuticals Revenue Forecast by Regions 2021-2026
12.2 North America Pet Pharmaceuticals Market Size Forecast (2021-2026)
12.2.1 North America: Pet Pharmaceuticals Sales Forecast (2021-2026)
12.2.2 North America: Pet Pharmaceuticals Revenue Forecast (2021-2026)
12.2.3 North America: Pet Pharmaceuticals Market Size Forecast by Country (2021-2026)
12.3 Europe Pet Pharmaceuticals Market Size Forecast (2021-2026)
12.3.1 Europe: Pet Pharmaceuticals Sales Forecast (2021-2026)
12.3.2 Europe: Pet Pharmaceuticals Revenue Forecast (2021-2026)
12.3.3 Europe: Pet Pharmaceuticals Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Pet Pharmaceuticals Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Pet Pharmaceuticals Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Pet Pharmaceuticals Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Pet Pharmaceuticals Market Size Forecast by Region (2021-2026)
12.5 Latin America Pet Pharmaceuticals Market Size Forecast (2021-2026)
12.5.1 Latin America: Pet Pharmaceuticals Sales Forecast (2021-2026)
12.5.2 Latin America: Pet Pharmaceuticals Revenue Forecast (2021-2026)
12.5.3 Latin America: Pet Pharmaceuticals Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Pet Pharmaceuticals Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Pet Pharmaceuticals Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Pet Pharmaceuticals Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Pet Pharmaceuticals Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Pet Pharmaceuticals Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Pet Pharmaceuticals Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Pet Pharmaceuticals Market Segments
Table 2. Ranking of Global Top Pet Pharmaceuticals Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pet Pharmaceuticals Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Pill
Table 5. Major Manufacturers of Injection
Table 6. Major Manufacturers of Spray
Table 7. Major Manufacturers of Ointment
Table 8. Major Manufacturers of Others
Table 9. COVID-19 Impact Global Market: (Four Pet Pharmaceuticals Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Pet Pharmaceuticals Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Pet Pharmaceuticals Players to Combat Covid-19 Impact
Table 14. Global Pet Pharmaceuticals Market Size Growth Rate by Application 2020-2026 (K MT)
Table 15. Global Pet Pharmaceuticals Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 16. Global Pet Pharmaceuticals Sales by Regions 2015-2020 (K MT)
Table 17. Global Pet Pharmaceuticals Sales Market Share by Regions (2015-2020)
Table 18. Global Pet Pharmaceuticals Revenue by Regions 2015-2020 (US$ Million)
Table 19. Global Pet Pharmaceuticals Sales by Manufacturers (2015-2020) (K MT)
Table 20. Global Pet Pharmaceuticals Sales Share by Manufacturers (2015-2020)
Table 21. Global Pet Pharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 22. Global Pet Pharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pet Pharmaceuticals as of 2019)
Table 23. Pet Pharmaceuticals Revenue by Manufacturers (2015-2020) (US$ Million)
Table 24. Pet Pharmaceuticals Revenue Share by Manufacturers (2015-2020)
Table 25. Key Manufacturers Pet Pharmaceuticals Price (2015-2020) (USD/MT)
Table 26. Pet Pharmaceuticals Manufacturers Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Pet Pharmaceuticals Product Type
Table 28. Date of International Manufacturers Enter into Pet Pharmaceuticals Market
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. Global Pet Pharmaceuticals Sales by Type (2015-2020) (K MT)
Table 31. Global Pet Pharmaceuticals Sales Share by Type (2015-2020)
Table 32. Global Pet Pharmaceuticals Revenue by Type (2015-2020) (US$ Million)
Table 33. Global Pet Pharmaceuticals Revenue Share by Type (2015-2020)
Table 34. Pet Pharmaceuticals Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 35. Global Pet Pharmaceuticals Sales by Application (2015-2020) (K MT)
Table 36. Global Pet Pharmaceuticals Sales Share by Application (2015-2020)
Table 37. North America Pet Pharmaceuticals Sales by Country (2015-2020) (K MT)
Table 38. North America Pet Pharmaceuticals Sales Market Share by Country (2015-2020)
Table 39. North America Pet Pharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 40. North America Pet Pharmaceuticals Revenue Market Share by Country (2015-2020)
Table 41. North America Pet Pharmaceuticals Sales by Type (2015-2020) (K MT)
Table 42. North America Pet Pharmaceuticals Sales Market Share by Type (2015-2020)
Table 43. North America Pet Pharmaceuticals Sales by Application (2015-2020) (K MT)
Table 44. North America Pet Pharmaceuticals Sales Market Share by Application (2015-2020)
Table 45. Europe Pet Pharmaceuticals Sales by Country (2015-2020) (K MT)
Table 46. Europe Pet Pharmaceuticals Sales Market Share by Country (2015-2020)
Table 47. Europe Pet Pharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 48. Europe Pet Pharmaceuticals Revenue Market Share by Country (2015-2020)
Table 49. Europe Pet Pharmaceuticals Sales by Type (2015-2020) (K MT)
Table 50. Europe Pet Pharmaceuticals Sales Market Share by Type (2015-2020)
Table 51. Europe Pet Pharmaceuticals Sales by Application (2015-2020) (K MT)
Table 52. Europe Pet Pharmaceuticals Sales Market Share by Application (2015-2020)
Table 53. Asia Pacific Pet Pharmaceuticals Sales by Region (2015-2020) (K MT)
Table 54. Asia Pacific Pet Pharmaceuticals Sales Market Share by Region (2015-2020)
Table 55. Asia Pacific Pet Pharmaceuticals Revenue by Region (2015-2020) (US$ Million)
Table 56. Asia Pacific Pet Pharmaceuticals Revenue Market Share by Region (2015-2020)
Table 57. Asia Pacific Pet Pharmaceuticals Sales by Type (2015-2020) (K MT)
Table 58. Asia Pacific Pet Pharmaceuticals Sales Market Share by Type (2015-2020)
Table 59. Asia Pacific Pet Pharmaceuticals Sales by Application (2015-2020) (K MT)
Table 60. Asia Pacific Pet Pharmaceuticals Sales Market Share by Application (2015-2020)
Table 61. Latin America Pet Pharmaceuticals Sales by Country (2015-2020) (K MT)
Table 62. Latin America Pet Pharmaceuticals Sales Market Share by Country (2015-2020)
Table 63. Latin Americaa Pet Pharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 64. Latin America Pet Pharmaceuticals Revenue Market Share by Country (2015-2020)
Table 65. Latin America Pet Pharmaceuticals Sales by Type (2015-2020) (K MT)
Table 66. Latin America Pet Pharmaceuticals Sales Market Share by Type (2015-2020)
Table 67. Latin America Pet Pharmaceuticals Sales by Application (2015-2020) (K MT)
Table 68. Latin America Pet Pharmaceuticals Sales Market Share by Application (2015-2020)
Table 69. Middle East and Africa Pet Pharmaceuticals Sales by Country (2015-2020) (K MT)
Table 70. Middle East and Africa Pet Pharmaceuticals Sales Market Share by Country (2015-2020)
Table 71. Middle East and Africa Pet Pharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 72. Middle East and Africa Pet Pharmaceuticals Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Pet Pharmaceuticals Sales by Type (2015-2020) (K MT)
Table 74. Middle East and Africa Pet Pharmaceuticals Sales Market Share by Type (2015-2020)
Table 75. Middle East and Africa Pet Pharmaceuticals Sales by Application (2015-2020) (K MT)
Table 76. Middle East and Africa Pet Pharmaceuticals Sales Market Share by Application (2015-2020)
Table 77. Zoetis Corporation Information
Table 78. Zoetis Description and Major Businesses
Table 79. Zoetis Pet Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 80. Zoetis Product
Table 81. Zoetis Recent Development
Table 82. Merck Animal Health Corporation Information
Table 83. Merck Animal Health Description and Major Businesses
Table 84. Merck Animal Health Pet Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 85. Merck Animal Health Product
Table 86. Merck Animal Health Recent Development
Table 87. Merial Corporation Information
Table 88. Merial Description and Major Businesses
Table 89. Merial Pet Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 90. Merial Product
Table 91. Merial Recent Development
Table 92. Elanco Corporation Information
Table 93. Elanco Description and Major Businesses
Table 94. Elanco Pet Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 95. Elanco Product
Table 96. Elanco Recent Development
Table 97. Bayer Corporation Information
Table 98. Bayer Description and Major Businesses
Table 99. Bayer Pet Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 100. Bayer Product
Table 101. Bayer Recent Development
Table 102. Boehringer Ingolheim Corporation Information
Table 103. Boehringer Ingolheim Description and Major Businesses
Table 104. Boehringer Ingolheim Pet Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 105. Boehringer Ingolheim Product
Table 106. Boehringer Ingolheim Recent Development
Table 107. Novartis Corporation Information
Table 108. Novartis Description and Major Businesses
Table 109. Novartis Pet Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 110. Novartis Product
Table 111. Novartis Recent Development
Table 112. Virbac Group Corporation Information
Table 113. Virbac Group Description and Major Businesses
Table 114. Virbac Group Pet Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 115. Virbac Group Product
Table 116. Virbac Group Recent Development
Table 117. Ceva Sante Animale Corporation Information
Table 118. Ceva Sante Animale Description and Major Businesses
Table 119. Ceva Sante Animale Pet Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 120. Ceva Sante Animale Product
Table 121. Ceva Sante Animale Recent Development
Table 122. V?toquinol S.A. Corporation Information
Table 123. V?toquinol S.A. Description and Major Businesses
Table 124. V?toquinol S.A. Pet Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 125. V?toquinol S.A. Product
Table 126. V?toquinol S.A. Recent Development
Table 127. Global Pet Pharmaceuticals Sales Forecast by Regions (2021-2026) (K MT)
Table 128. Global Pet Pharmaceuticals Sales Market Share Forecast by Regions (2021-2026)
Table 129. Global Pet Pharmaceuticals Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 130. Global Pet Pharmaceuticals Revenue Market Share Forecast by Regions (2021-2026)
Table 131. North America: Pet Pharmaceuticals Sales Forecast by Country (2021-2026) (K MT)
Table 132. North America: Pet Pharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Europe: Pet Pharmaceuticals Sales Forecast by Country (2021-2026) (K MT)
Table 134. Europe: Pet Pharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Asia Pacific: Pet Pharmaceuticals Sales Forecast by Region (2021-2026) (K MT)
Table 136. Asia Pacific: Pet Pharmaceuticals Revenue Forecast by Region (2021-2026) (US$ Million)
Table 137. Latin America: Pet Pharmaceuticals Sales Forecast by Country (2021-2026) (K MT)
Table 138. Latin America: Pet Pharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Middle East and Africa: Pet Pharmaceuticals Sales Forecast by Country (2021-2026) (K MT)
Table 140. Middle East and Africa: Pet Pharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 142. Key Challenges
Table 143. Market Risks
Table 144. Main Points Interviewed from Key Pet Pharmaceuticals Players
Table 145. Pet Pharmaceuticals Customers List
Table 146. Pet Pharmaceuticals Distributors List
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
Table 1. Pet Pharmaceuticals Market Segments
Table 2. Ranking of Global Top Pet Pharmaceuticals Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pet Pharmaceuticals Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Pill
Table 5. Major Manufacturers of Injection
Table 6. Major Manufacturers of Spray
Table 7. Major Manufacturers of Ointment
Table 8. Major Manufacturers of Others
Table 9. COVID-19 Impact Global Market: (Four Pet Pharmaceuticals Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Pet Pharmaceuticals Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Pet Pharmaceuticals Players to Combat Covid-19 Impact
Table 14. Global Pet Pharmaceuticals Market Size Growth Rate by Application 2020-2026 (K MT)
Table 15. Global Pet Pharmaceuticals Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 16. Global Pet Pharmaceuticals Sales by Regions 2015-2020 (K MT)
Table 17. Global Pet Pharmaceuticals Sales Market Share by Regions (2015-2020)
Table 18. Global Pet Pharmaceuticals Revenue by Regions 2015-2020 (US$ Million)
Table 19. Global Pet Pharmaceuticals Sales by Manufacturers (2015-2020) (K MT)
Table 20. Global Pet Pharmaceuticals Sales Share by Manufacturers (2015-2020)
Table 21. Global Pet Pharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 22. Global Pet Pharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pet Pharmaceuticals as of 2019)
Table 23. Pet Pharmaceuticals Revenue by Manufacturers (2015-2020) (US$ Million)
Table 24. Pet Pharmaceuticals Revenue Share by Manufacturers (2015-2020)
Table 25. Key Manufacturers Pet Pharmaceuticals Price (2015-2020) (USD/MT)
Table 26. Pet Pharmaceuticals Manufacturers Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Pet Pharmaceuticals Product Type
Table 28. Date of International Manufacturers Enter into Pet Pharmaceuticals Market
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. Global Pet Pharmaceuticals Sales by Type (2015-2020) (K MT)
Table 31. Global Pet Pharmaceuticals Sales Share by Type (2015-2020)
Table 32. Global Pet Pharmaceuticals Revenue by Type (2015-2020) (US$ Million)
Table 33. Global Pet Pharmaceuticals Revenue Share by Type (2015-2020)
Table 34. Pet Pharmaceuticals Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 35. Global Pet Pharmaceuticals Sales by Application (2015-2020) (K MT)
Table 36. Global Pet Pharmaceuticals Sales Share by Application (2015-2020)
Table 37. North America Pet Pharmaceuticals Sales by Country (2015-2020) (K MT)
Table 38. North America Pet Pharmaceuticals Sales Market Share by Country (2015-2020)
Table 39. North America Pet Pharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 40. North America Pet Pharmaceuticals Revenue Market Share by Country (2015-2020)
Table 41. North America Pet Pharmaceuticals Sales by Type (2015-2020) (K MT)
Table 42. North America Pet Pharmaceuticals Sales Market Share by Type (2015-2020)
Table 43. North America Pet Pharmaceuticals Sales by Application (2015-2020) (K MT)
Table 44. North America Pet Pharmaceuticals Sales Market Share by Application (2015-2020)
Table 45. Europe Pet Pharmaceuticals Sales by Country (2015-2020) (K MT)
Table 46. Europe Pet Pharmaceuticals Sales Market Share by Country (2015-2020)
Table 47. Europe Pet Pharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 48. Europe Pet Pharmaceuticals Revenue Market Share by Country (2015-2020)
Table 49. Europe Pet Pharmaceuticals Sales by Type (2015-2020) (K MT)
Table 50. Europe Pet Pharmaceuticals Sales Market Share by Type (2015-2020)
Table 51. Europe Pet Pharmaceuticals Sales by Application (2015-2020) (K MT)
Table 52. Europe Pet Pharmaceuticals Sales Market Share by Application (2015-2020)
Table 53. Asia Pacific Pet Pharmaceuticals Sales by Region (2015-2020) (K MT)
Table 54. Asia Pacific Pet Pharmaceuticals Sales Market Share by Region (2015-2020)
Table 55. Asia Pacific Pet Pharmaceuticals Revenue by Region (2015-2020) (US$ Million)
Table 56. Asia Pacific Pet Pharmaceuticals Revenue Market Share by Region (2015-2020)
Table 57. Asia Pacific Pet Pharmaceuticals Sales by Type (2015-2020) (K MT)
Table 58. Asia Pacific Pet Pharmaceuticals Sales Market Share by Type (2015-2020)
Table 59. Asia Pacific Pet Pharmaceuticals Sales by Application (2015-2020) (K MT)
Table 60. Asia Pacific Pet Pharmaceuticals Sales Market Share by Application (2015-2020)
Table 61. Latin America Pet Pharmaceuticals Sales by Country (2015-2020) (K MT)
Table 62. Latin America Pet Pharmaceuticals Sales Market Share by Country (2015-2020)
Table 63. Latin Americaa Pet Pharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 64. Latin America Pet Pharmaceuticals Revenue Market Share by Country (2015-2020)
Table 65. Latin America Pet Pharmaceuticals Sales by Type (2015-2020) (K MT)
Table 66. Latin America Pet Pharmaceuticals Sales Market Share by Type (2015-2020)
Table 67. Latin America Pet Pharmaceuticals Sales by Application (2015-2020) (K MT)
Table 68. Latin America Pet Pharmaceuticals Sales Market Share by Application (2015-2020)
Table 69. Middle East and Africa Pet Pharmaceuticals Sales by Country (2015-2020) (K MT)
Table 70. Middle East and Africa Pet Pharmaceuticals Sales Market Share by Country (2015-2020)
Table 71. Middle East and Africa Pet Pharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 72. Middle East and Africa Pet Pharmaceuticals Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Pet Pharmaceuticals Sales by Type (2015-2020) (K MT)
Table 74. Middle East and Africa Pet Pharmaceuticals Sales Market Share by Type (2015-2020)
Table 75. Middle East and Africa Pet Pharmaceuticals Sales by Application (2015-2020) (K MT)
Table 76. Middle East and Africa Pet Pharmaceuticals Sales Market Share by Application (2015-2020)
Table 77. Zoetis Corporation Information
Table 78. Zoetis Description and Major Businesses
Table 79. Zoetis Pet Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 80. Zoetis Product
Table 81. Zoetis Recent Development
Table 82. Merck Animal Health Corporation Information
Table 83. Merck Animal Health Description and Major Businesses
Table 84. Merck Animal Health Pet Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 85. Merck Animal Health Product
Table 86. Merck Animal Health Recent Development
Table 87. Merial Corporation Information
Table 88. Merial Description and Major Businesses
Table 89. Merial Pet Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 90. Merial Product
Table 91. Merial Recent Development
Table 92. Elanco Corporation Information
Table 93. Elanco Description and Major Businesses
Table 94. Elanco Pet Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 95. Elanco Product
Table 96. Elanco Recent Development
Table 97. Bayer Corporation Information
Table 98. Bayer Description and Major Businesses
Table 99. Bayer Pet Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 100. Bayer Product
Table 101. Bayer Recent Development
Table 102. Boehringer Ingolheim Corporation Information
Table 103. Boehringer Ingolheim Description and Major Businesses
Table 104. Boehringer Ingolheim Pet Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 105. Boehringer Ingolheim Product
Table 106. Boehringer Ingolheim Recent Development
Table 107. Novartis Corporation Information
Table 108. Novartis Description and Major Businesses
Table 109. Novartis Pet Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 110. Novartis Product
Table 111. Novartis Recent Development
Table 112. Virbac Group Corporation Information
Table 113. Virbac Group Description and Major Businesses
Table 114. Virbac Group Pet Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 115. Virbac Group Product
Table 116. Virbac Group Recent Development
Table 117. Ceva Sante Animale Corporation Information
Table 118. Ceva Sante Animale Description and Major Businesses
Table 119. Ceva Sante Animale Pet Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 120. Ceva Sante Animale Product
Table 121. Ceva Sante Animale Recent Development
Table 122. V?toquinol S.A. Corporation Information
Table 123. V?toquinol S.A. Description and Major Businesses
Table 124. V?toquinol S.A. Pet Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 125. V?toquinol S.A. Product
Table 126. V?toquinol S.A. Recent Development
Table 127. Global Pet Pharmaceuticals Sales Forecast by Regions (2021-2026) (K MT)
Table 128. Global Pet Pharmaceuticals Sales Market Share Forecast by Regions (2021-2026)
Table 129. Global Pet Pharmaceuticals Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 130. Global Pet Pharmaceuticals Revenue Market Share Forecast by Regions (2021-2026)
Table 131. North America: Pet Pharmaceuticals Sales Forecast by Country (2021-2026) (K MT)
Table 132. North America: Pet Pharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Europe: Pet Pharmaceuticals Sales Forecast by Country (2021-2026) (K MT)
Table 134. Europe: Pet Pharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Asia Pacific: Pet Pharmaceuticals Sales Forecast by Region (2021-2026) (K MT)
Table 136. Asia Pacific: Pet Pharmaceuticals Revenue Forecast by Region (2021-2026) (US$ Million)
Table 137. Latin America: Pet Pharmaceuticals Sales Forecast by Country (2021-2026) (K MT)
Table 138. Latin America: Pet Pharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Middle East and Africa: Pet Pharmaceuticals Sales Forecast by Country (2021-2026) (K MT)
Table 140. Middle East and Africa: Pet Pharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 142. Key Challenges
Table 143. Market Risks
Table 144. Main Points Interviewed from Key Pet Pharmaceuticals Players
Table 145. Pet Pharmaceuticals Customers List
Table 146. Pet Pharmaceuticals Distributors List
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Pet Pharmaceuticals Product Picture
Figure 2. Global Pet Pharmaceuticals Sales Market Share by Type in 2020 & 2026
Figure 3. Pill Product Picture
Figure 4. Injection Product Picture
Figure 5. Spray Product Picture
Figure 6. Ointment Product Picture
Figure 7. Others Product Picture
Figure 8. Global Pet Pharmaceuticals Sales Market Share by Application in 2020 & 2026
Figure 9. Treatment
Figure 10. Prevention
Figure 11. Pet Pharmaceuticals Report Years Considered
Figure 12. Global Pet Pharmaceuticals Market Size 2015-2026 (US$ Million)
Figure 13. Global Pet Pharmaceuticals Sales 2015-2026 (K MT)
Figure 14. Global Pet Pharmaceuticals Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Pet Pharmaceuticals Sales Market Share by Region (2015-2020)
Figure 16. Global Pet Pharmaceuticals Sales Market Share by Region in 2019
Figure 17. Global Pet Pharmaceuticals Revenue Market Share by Region (2015-2020)
Figure 18. Global Pet Pharmaceuticals Revenue Market Share by Region in 2019
Figure 19. Global Pet Pharmaceuticals Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Pet Pharmaceuticals Revenue in 2019
Figure 21. Pet Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Pet Pharmaceuticals Sales Market Share by Type (2015-2020)
Figure 23. Global Pet Pharmaceuticals Sales Market Share by Type in 2019
Figure 24. Global Pet Pharmaceuticals Revenue Market Share by Type (2015-2020)
Figure 25. Global Pet Pharmaceuticals Revenue Market Share by Type in 2019
Figure 26. Global Pet Pharmaceuticals Market Share by Price Range (2015-2020)
Figure 27. Global Pet Pharmaceuticals Sales Market Share by Application (2015-2020)
Figure 28. Global Pet Pharmaceuticals Sales Market Share by Application in 2019
Figure 29. Global Pet Pharmaceuticals Revenue Market Share by Application (2015-2020)
Figure 30. Global Pet Pharmaceuticals Revenue Market Share by Application in 2019
Figure 31. North America Pet Pharmaceuticals Sales Growth Rate 2015-2020 (K MT)
Figure 32. North America Pet Pharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Pet Pharmaceuticals Sales Market Share by Country in 2019
Figure 34. North America Pet Pharmaceuticals Revenue Market Share by Country in 2019
Figure 35. U.S. Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 36. U.S. Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 38. Canada Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Pet Pharmaceuticals Market Share by Type in 2019
Figure 40. North America Pet Pharmaceuticals Market Share by Application in 2019
Figure 41. Europe Pet Pharmaceuticals Sales Growth Rate 2015-2020 (K MT)
Figure 42. Europe Pet Pharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Pet Pharmaceuticals Sales Market Share by Country in 2019
Figure 44. Europe Pet Pharmaceuticals Revenue Market Share by Country in 2019
Figure 45. Germany Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 46. Germany Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 48. France Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 50. U.K. Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 52. Italy Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 54. Russia Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Pet Pharmaceuticals Market Share by Type in 2019
Figure 56. Europe Pet Pharmaceuticals Market Share by Application in 2019
Figure 57. Asia Pacific Pet Pharmaceuticals Sales Growth Rate 2015-2020 (K MT)
Figure 58. Asia Pacific Pet Pharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Pet Pharmaceuticals Sales Market Share by Region in 2019
Figure 60. Asia Pacific Pet Pharmaceuticals Revenue Market Share by Region in 2019
Figure 61. China Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 62. China Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 64. Japan Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 66. South Korea Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 68. India Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 70. Australia Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 72. Taiwan Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 74. Indonesia Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 76. Thailand Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 78. Malaysia Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 80. Philippines Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 82. Vietnam Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Pet Pharmaceuticals Market Share by Type in 2019
Figure 84. Asia Pacific Pet Pharmaceuticals Market Share by Application in 2019
Figure 85. Latin America Pet Pharmaceuticals Sales Growth Rate 2015-2020 (K MT)
Figure 86. Latin America Pet Pharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Pet Pharmaceuticals Sales Market Share by Country in 2019
Figure 88. Latin America Pet Pharmaceuticals Revenue Market Share by Country in 2019
Figure 89. Mexico Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 90. Mexico Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 92. Brazil Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 94. Argentina Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Pet Pharmaceuticals Market Share by Type in 2019
Figure 96. Latin America Pet Pharmaceuticals Market Share by Application in 2019
Figure 97. Middle East and Africa Pet Pharmaceuticals Sales Growth Rate 2015-2020 (K MT)
Figure 98. Middle East and Africa Pet Pharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Pet Pharmaceuticals Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Pet Pharmaceuticals Revenue Market Share by Country in 2019
Figure 101. Turkey Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 102. Turkey Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 104. Saudi Arabia Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 106. U.A.E Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Pet Pharmaceuticals Market Share by Type in 2019
Figure 108. Middle East and Africa Pet Pharmaceuticals Market Share by Application in 2019
Figure 109. Zoetis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Merck Animal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Merial Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Elanco Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Boehringer Ingolheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Virbac Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Ceva Sante Animale Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. V?toquinol S.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. North America Pet Pharmaceuticals Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 120. North America Pet Pharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Europe Pet Pharmaceuticals Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 122. Europe Pet Pharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Asia Pacific Pet Pharmaceuticals Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 124. Asia Pacific Pet Pharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Latin America Pet Pharmaceuticals Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 126. Latin America Pet Pharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Middle East and Africa Pet Pharmaceuticals Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 128. Middle East and Africa Pet Pharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Porter's Five Forces Analysis
Figure 130. Channels of Distribution
Figure 131. Distributors Profiles
Figure 132. Bottom-up and Top-down Approaches for This Report
Figure 133. Data Triangulation
Figure 134. Key Executives Interviewed
Figure 1. Pet Pharmaceuticals Product Picture
Figure 2. Global Pet Pharmaceuticals Sales Market Share by Type in 2020 & 2026
Figure 3. Pill Product Picture
Figure 4. Injection Product Picture
Figure 5. Spray Product Picture
Figure 6. Ointment Product Picture
Figure 7. Others Product Picture
Figure 8. Global Pet Pharmaceuticals Sales Market Share by Application in 2020 & 2026
Figure 9. Treatment
Figure 10. Prevention
Figure 11. Pet Pharmaceuticals Report Years Considered
Figure 12. Global Pet Pharmaceuticals Market Size 2015-2026 (US$ Million)
Figure 13. Global Pet Pharmaceuticals Sales 2015-2026 (K MT)
Figure 14. Global Pet Pharmaceuticals Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Pet Pharmaceuticals Sales Market Share by Region (2015-2020)
Figure 16. Global Pet Pharmaceuticals Sales Market Share by Region in 2019
Figure 17. Global Pet Pharmaceuticals Revenue Market Share by Region (2015-2020)
Figure 18. Global Pet Pharmaceuticals Revenue Market Share by Region in 2019
Figure 19. Global Pet Pharmaceuticals Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Pet Pharmaceuticals Revenue in 2019
Figure 21. Pet Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Pet Pharmaceuticals Sales Market Share by Type (2015-2020)
Figure 23. Global Pet Pharmaceuticals Sales Market Share by Type in 2019
Figure 24. Global Pet Pharmaceuticals Revenue Market Share by Type (2015-2020)
Figure 25. Global Pet Pharmaceuticals Revenue Market Share by Type in 2019
Figure 26. Global Pet Pharmaceuticals Market Share by Price Range (2015-2020)
Figure 27. Global Pet Pharmaceuticals Sales Market Share by Application (2015-2020)
Figure 28. Global Pet Pharmaceuticals Sales Market Share by Application in 2019
Figure 29. Global Pet Pharmaceuticals Revenue Market Share by Application (2015-2020)
Figure 30. Global Pet Pharmaceuticals Revenue Market Share by Application in 2019
Figure 31. North America Pet Pharmaceuticals Sales Growth Rate 2015-2020 (K MT)
Figure 32. North America Pet Pharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Pet Pharmaceuticals Sales Market Share by Country in 2019
Figure 34. North America Pet Pharmaceuticals Revenue Market Share by Country in 2019
Figure 35. U.S. Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 36. U.S. Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 38. Canada Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Pet Pharmaceuticals Market Share by Type in 2019
Figure 40. North America Pet Pharmaceuticals Market Share by Application in 2019
Figure 41. Europe Pet Pharmaceuticals Sales Growth Rate 2015-2020 (K MT)
Figure 42. Europe Pet Pharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Pet Pharmaceuticals Sales Market Share by Country in 2019
Figure 44. Europe Pet Pharmaceuticals Revenue Market Share by Country in 2019
Figure 45. Germany Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 46. Germany Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 48. France Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 50. U.K. Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 52. Italy Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 54. Russia Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Pet Pharmaceuticals Market Share by Type in 2019
Figure 56. Europe Pet Pharmaceuticals Market Share by Application in 2019
Figure 57. Asia Pacific Pet Pharmaceuticals Sales Growth Rate 2015-2020 (K MT)
Figure 58. Asia Pacific Pet Pharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Pet Pharmaceuticals Sales Market Share by Region in 2019
Figure 60. Asia Pacific Pet Pharmaceuticals Revenue Market Share by Region in 2019
Figure 61. China Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 62. China Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 64. Japan Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 66. South Korea Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 68. India Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 70. Australia Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 72. Taiwan Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 74. Indonesia Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 76. Thailand Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 78. Malaysia Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 80. Philippines Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 82. Vietnam Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Pet Pharmaceuticals Market Share by Type in 2019
Figure 84. Asia Pacific Pet Pharmaceuticals Market Share by Application in 2019
Figure 85. Latin America Pet Pharmaceuticals Sales Growth Rate 2015-2020 (K MT)
Figure 86. Latin America Pet Pharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Pet Pharmaceuticals Sales Market Share by Country in 2019
Figure 88. Latin America Pet Pharmaceuticals Revenue Market Share by Country in 2019
Figure 89. Mexico Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 90. Mexico Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 92. Brazil Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 94. Argentina Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Pet Pharmaceuticals Market Share by Type in 2019
Figure 96. Latin America Pet Pharmaceuticals Market Share by Application in 2019
Figure 97. Middle East and Africa Pet Pharmaceuticals Sales Growth Rate 2015-2020 (K MT)
Figure 98. Middle East and Africa Pet Pharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Pet Pharmaceuticals Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Pet Pharmaceuticals Revenue Market Share by Country in 2019
Figure 101. Turkey Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 102. Turkey Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 104. Saudi Arabia Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Pet Pharmaceuticals Sales Growth Rate (2015-2020) (K MT)
Figure 106. U.A.E Pet Pharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Pet Pharmaceuticals Market Share by Type in 2019
Figure 108. Middle East and Africa Pet Pharmaceuticals Market Share by Application in 2019
Figure 109. Zoetis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Merck Animal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Merial Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Elanco Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Boehringer Ingolheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Virbac Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Ceva Sante Animale Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. V?toquinol S.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. North America Pet Pharmaceuticals Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 120. North America Pet Pharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Europe Pet Pharmaceuticals Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 122. Europe Pet Pharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Asia Pacific Pet Pharmaceuticals Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 124. Asia Pacific Pet Pharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Latin America Pet Pharmaceuticals Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 126. Latin America Pet Pharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Middle East and Africa Pet Pharmaceuticals Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 128. Middle East and Africa Pet Pharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Porter's Five Forces Analysis
Figure 130. Channels of Distribution
Figure 131. Distributors Profiles
Figure 132. Bottom-up and Top-down Approaches for This Report
Figure 133. Data Triangulation
Figure 134. Key Executives Interviewed
